GO
Loading...

Acorda CEO: Filed for approval of Diazepam nasal spray

Tuesday, 5 Nov 2013 | 6:15 PM ET

Acorda Therapeutics president & CEO Dr. Ron Cohen discusses its pipeline and current research, whether epilepsy is an epidemic and its plan for its Diazepam nasal spray.